In summary, we observed a novel interplay between Smad1 and Smad3 signaling under diabetic conditions and found that phosphorylation of the Smad1 linker domain may play a crucial role in DN progression (Fig. 9). This evidence concerns the gene SMAD3 and liver dysplastic nodule.